![Bernard Mach](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bernard Mach
Founder at MaxiVAX SA
Bernard Mach active positions
Companies | Position | Start | End |
---|---|---|---|
MaxiVAX SA
![]() MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Director/Board Member | 01/01/2005 | - |
Founder | 01/01/2005 | - |
Career history of Bernard Mach
Former positions of Bernard Mach
Companies | Position | Start | End |
---|---|---|---|
LO FUNDS LIFE SCIENCES EXPERTISE | Founder | - | 28/03/2014 |
Corporate Officer/Principal | - | - | |
Serono SA
![]() Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Director/Board Member | 01/01/1997 | 17/01/2007 |
University of Geneva | Corporate Officer/Principal | - | 01/01/1998 |
NOVIMMUNE SA | Director/Board Member | 27/04/2010 | - |
Founder | 27/04/2010 | - | |
LONZA GROUP AG | Director/Board Member | - | - |
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Founder | - | - |
Training of Bernard Mach
The Rockefeller University | Doctorate Degree |
University of Geneva | Doctorate Degree |
Statistics
International
Switzerland | 7 |
United States | 3 |
Operational
Director/Board Member | 5 |
Founder | 4 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
LONZA GROUP AG | Health Technology |
Private companies | 5 |
---|---|
Biogen MA, Inc.
![]() Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Serono SA
![]() Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
LO FUNDS LIFE SCIENCES EXPERTISE | Miscellaneous |
Novimmune SA
![]() Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
MaxiVAX SA
![]() MaxiVAX SA Miscellaneous Commercial ServicesCommercial Services MaxiVAX SA is a Swiss clinical stage biotechnology company. The private company is based in Geneva, Switzerland. The company was founded by Bernard Mach. | Commercial Services |
- Stock Market
- Insiders
- Bernard Mach
- Experience